A detailed history of Lazard Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,313,423 shares of NVO stock, worth $115 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,313,423
Previous 1,155,500 13.67%
Holding current value
$115 Million
Previous $165 Million 5.18%
% of portfolio
0.23%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $18.8 Million - $23 Million
157,923 Added 13.67%
1,313,423 $156 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $10.1 Million - $12.1 Million
-82,386 Reduced 6.66%
1,155,500 $165 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $22.6 Million - $30.1 Million
-221,308 Reduced 15.17%
1,237,886 $159 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $3.07 Million - $3.69 Million
-35,020 Reduced 2.34%
1,459,194 $151 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $87.7 Million - $192 Million
964,640 Added 182.15%
1,494,214 $136 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $81.8 Million - $90.5 Million
524,139 Added 9643.77%
529,574 $85.7 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $19,453 - $23,393
147 Added 2.78%
5,435 $864,000
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $91,064 - $120,173
-888 Reduced 14.38%
5,288 $715,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $586,353 - $719,587
6,154 Added 27972.73%
6,176 $615,000
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $2,271 - $2,679
22 New
22 $2,000
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $163,192 - $178,827
-3,490 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$44.29 - $50.42 $23,695 - $26,974
-535 Reduced 13.29%
3,490 $160,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $2,909 - $3,488
-60 Reduced 1.47%
4,025 $198,000
Q4 2017

Aug 28, 2019

BUY
$47.53 - $53.73 $2,851 - $3,223
60 Added 1.49%
4,085 $219,000
Q4 2017

Feb 13, 2018

SELL
$47.53 - $53.73 $2,851 - $3,223
-60 Reduced 1.47%
4,025 $216,000
Q3 2017

Aug 19, 2019

BUY
$41.15 - $49.22 $2,469 - $2,953
60 Added 1.49%
4,085 $196,000
Q3 2017

Nov 13, 2017

SELL
$41.15 - $49.22 $8.42 Million - $10.1 Million
-204,587 Reduced 98.07%
4,025 $193,000
Q2 2017

Aug 19, 2019

SELL
N/A
-2,190 Reduced 1.04%
208,612 $8.95 Million
Q1 2017

Aug 13, 2019

BUY
N/A
2,453 Added 1.18%
210,802 $7.23 Million
Q4 2016

Jul 30, 2019

SELL
N/A
-100,870 Reduced 32.62%
208,349 $7.47 Million
Q3 2016

Aug 07, 2019

SELL
N/A
-1,585,708 Reduced 83.68%
309,219 $12.9 Million
Q2 2016

Jul 29, 2019

BUY
N/A
34,447 Added 1.85%
1,894,927 $102 Million
Q1 2016

Jul 25, 2019

BUY
N/A
110,759 Added 6.33%
1,860,480 $101 Million
Q4 2015

Jul 24, 2019

SELL
N/A
-390,874 Reduced 18.26%
1,749,721 $102 Million
Q3 2015

Jul 15, 2019

BUY
N/A
60,529 Added 2.91%
2,140,595 $116 Million
Q2 2015

Jul 08, 2019

BUY
N/A
62,732 Added 3.11%
2,080,066 $114 Million
Q4 2014

Aug 29, 2019

BUY
N/A
2,017,334
2,017,334 $85.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.